Treatment of renal calculi by lithotripsy

Minimizing short-term shock wave induced renal damage by using antioxidants

Khaleel A. Al-Awadi, Elijah O. Kehinde, Issa Loutfi, Olusegun A. Mojiminiyi, Adel Al-Hunayan, Hamdy Abdul-Halim, Ahmed Al-Sarraf, Anjum Memon, Mathew P. Abraham

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Treatment with extracorporeal shock wave lithotripsy (ESWL), the preferred method of treating kidney stones <3 cm in size, has been shown to induce silent and often self-limiting acute and chronic lesions in the kidneys and adjacent organs. We conducted a randomized clinical trial to determine whether ESWL produces ischaemia and reperfusion injury in the kidneys and whether oral administration of antioxidants reduces the degree of short-term renal injury in patients treated with ESWL. The study included 120 patients with renal stones (1-3 cm in size) treated with ESWL. The patients were divided into three groups-patients in group A (n = 39) served as a control group and were not given any antioxidants; patients in group B (n = 41) were given two capsules of antioxidants "Nature Made r" 2 h before ESWL, and 2 and 8 h after ESWL; and patients in group C (n = 40) were given two capsules of the antioxidants 2 and 8 h after ESWL. Double 'J' stents were inserted in patients before treatment with ESWL. Blood and urine samples were obtained from all patients just before the start of treatment with ESWL, and at 2 and 24 h and on 7th and 28th day after ESWL. Serum levels of malondialdehyde (MDA), α-tocopherol, cholesterol, albumin and ascorbic acid, and α-tocopherol/cholesterol ratio were determined. Urinary levels of albumin and β2 microglobulin were also determined as measures of renal tubular injury. At 24 h after ESWL, patients given antioxidants (groups B + C) had significantly reduced mean serum concentration of MDA (P < 0.001); higher levels of serum ascorbic acid (P < 0.001) and serum albumin (P < 0.001); lower α-tocopherol/cholesterol ratio, lower urinary albumin and β2 microglobulin levels compared with patients who did not receive antioxidants (group A). These findings suggest that treatment with ESWL generates free radicals through ischaemic/reperfusion injury mechanism, and that oral administration of antioxidant may protect these patients from short term renal injury caused by ESWL.

Original languageEnglish
Pages (from-to)51-60
Number of pages10
JournalUrological Research
Volume36
Issue number1
DOIs
Publication statusPublished - Feb 2008
Externally publishedYes

Fingerprint

Kidney Calculi
Lithotripsy
Antioxidants
Kidney
Tocopherols
Therapeutics
Albumins
Cholesterol
Reperfusion Injury
Malondialdehyde
Ascorbic Acid
Capsules
Oral Administration
Wounds and Injuries
Serum
Serum Albumin
Free Radicals
Stents
Randomized Controlled Trials

Keywords

  • Antioxidants
  • Humans
  • Renal calculi
  • Renal injury
  • Shock waves

ASJC Scopus subject areas

  • Urology

Cite this

Al-Awadi, K. A., Kehinde, E. O., Loutfi, I., Mojiminiyi, O. A., Al-Hunayan, A., Abdul-Halim, H., ... Abraham, M. P. (2008). Treatment of renal calculi by lithotripsy: Minimizing short-term shock wave induced renal damage by using antioxidants. Urological Research, 36(1), 51-60. https://doi.org/10.1007/s00240-007-0126-0

Treatment of renal calculi by lithotripsy : Minimizing short-term shock wave induced renal damage by using antioxidants. / Al-Awadi, Khaleel A.; Kehinde, Elijah O.; Loutfi, Issa; Mojiminiyi, Olusegun A.; Al-Hunayan, Adel; Abdul-Halim, Hamdy; Al-Sarraf, Ahmed; Memon, Anjum; Abraham, Mathew P.

In: Urological Research, Vol. 36, No. 1, 02.2008, p. 51-60.

Research output: Contribution to journalArticle

Al-Awadi, KA, Kehinde, EO, Loutfi, I, Mojiminiyi, OA, Al-Hunayan, A, Abdul-Halim, H, Al-Sarraf, A, Memon, A & Abraham, MP 2008, 'Treatment of renal calculi by lithotripsy: Minimizing short-term shock wave induced renal damage by using antioxidants', Urological Research, vol. 36, no. 1, pp. 51-60. https://doi.org/10.1007/s00240-007-0126-0
Al-Awadi, Khaleel A. ; Kehinde, Elijah O. ; Loutfi, Issa ; Mojiminiyi, Olusegun A. ; Al-Hunayan, Adel ; Abdul-Halim, Hamdy ; Al-Sarraf, Ahmed ; Memon, Anjum ; Abraham, Mathew P. / Treatment of renal calculi by lithotripsy : Minimizing short-term shock wave induced renal damage by using antioxidants. In: Urological Research. 2008 ; Vol. 36, No. 1. pp. 51-60.
@article{b4cadf7b2a2946638fcfb7751a1436ce,
title = "Treatment of renal calculi by lithotripsy: Minimizing short-term shock wave induced renal damage by using antioxidants",
abstract = "Treatment with extracorporeal shock wave lithotripsy (ESWL), the preferred method of treating kidney stones <3 cm in size, has been shown to induce silent and often self-limiting acute and chronic lesions in the kidneys and adjacent organs. We conducted a randomized clinical trial to determine whether ESWL produces ischaemia and reperfusion injury in the kidneys and whether oral administration of antioxidants reduces the degree of short-term renal injury in patients treated with ESWL. The study included 120 patients with renal stones (1-3 cm in size) treated with ESWL. The patients were divided into three groups-patients in group A (n = 39) served as a control group and were not given any antioxidants; patients in group B (n = 41) were given two capsules of antioxidants {"}Nature Made r{"} 2 h before ESWL, and 2 and 8 h after ESWL; and patients in group C (n = 40) were given two capsules of the antioxidants 2 and 8 h after ESWL. Double 'J' stents were inserted in patients before treatment with ESWL. Blood and urine samples were obtained from all patients just before the start of treatment with ESWL, and at 2 and 24 h and on 7th and 28th day after ESWL. Serum levels of malondialdehyde (MDA), α-tocopherol, cholesterol, albumin and ascorbic acid, and α-tocopherol/cholesterol ratio were determined. Urinary levels of albumin and β2 microglobulin were also determined as measures of renal tubular injury. At 24 h after ESWL, patients given antioxidants (groups B + C) had significantly reduced mean serum concentration of MDA (P < 0.001); higher levels of serum ascorbic acid (P < 0.001) and serum albumin (P < 0.001); lower α-tocopherol/cholesterol ratio, lower urinary albumin and β2 microglobulin levels compared with patients who did not receive antioxidants (group A). These findings suggest that treatment with ESWL generates free radicals through ischaemic/reperfusion injury mechanism, and that oral administration of antioxidant may protect these patients from short term renal injury caused by ESWL.",
keywords = "Antioxidants, Humans, Renal calculi, Renal injury, Shock waves",
author = "Al-Awadi, {Khaleel A.} and Kehinde, {Elijah O.} and Issa Loutfi and Mojiminiyi, {Olusegun A.} and Adel Al-Hunayan and Hamdy Abdul-Halim and Ahmed Al-Sarraf and Anjum Memon and Abraham, {Mathew P.}",
year = "2008",
month = "2",
doi = "10.1007/s00240-007-0126-0",
language = "English",
volume = "36",
pages = "51--60",
journal = "Urolithiasis",
issn = "2194-7228",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Treatment of renal calculi by lithotripsy

T2 - Minimizing short-term shock wave induced renal damage by using antioxidants

AU - Al-Awadi, Khaleel A.

AU - Kehinde, Elijah O.

AU - Loutfi, Issa

AU - Mojiminiyi, Olusegun A.

AU - Al-Hunayan, Adel

AU - Abdul-Halim, Hamdy

AU - Al-Sarraf, Ahmed

AU - Memon, Anjum

AU - Abraham, Mathew P.

PY - 2008/2

Y1 - 2008/2

N2 - Treatment with extracorporeal shock wave lithotripsy (ESWL), the preferred method of treating kidney stones <3 cm in size, has been shown to induce silent and often self-limiting acute and chronic lesions in the kidneys and adjacent organs. We conducted a randomized clinical trial to determine whether ESWL produces ischaemia and reperfusion injury in the kidneys and whether oral administration of antioxidants reduces the degree of short-term renal injury in patients treated with ESWL. The study included 120 patients with renal stones (1-3 cm in size) treated with ESWL. The patients were divided into three groups-patients in group A (n = 39) served as a control group and were not given any antioxidants; patients in group B (n = 41) were given two capsules of antioxidants "Nature Made r" 2 h before ESWL, and 2 and 8 h after ESWL; and patients in group C (n = 40) were given two capsules of the antioxidants 2 and 8 h after ESWL. Double 'J' stents were inserted in patients before treatment with ESWL. Blood and urine samples were obtained from all patients just before the start of treatment with ESWL, and at 2 and 24 h and on 7th and 28th day after ESWL. Serum levels of malondialdehyde (MDA), α-tocopherol, cholesterol, albumin and ascorbic acid, and α-tocopherol/cholesterol ratio were determined. Urinary levels of albumin and β2 microglobulin were also determined as measures of renal tubular injury. At 24 h after ESWL, patients given antioxidants (groups B + C) had significantly reduced mean serum concentration of MDA (P < 0.001); higher levels of serum ascorbic acid (P < 0.001) and serum albumin (P < 0.001); lower α-tocopherol/cholesterol ratio, lower urinary albumin and β2 microglobulin levels compared with patients who did not receive antioxidants (group A). These findings suggest that treatment with ESWL generates free radicals through ischaemic/reperfusion injury mechanism, and that oral administration of antioxidant may protect these patients from short term renal injury caused by ESWL.

AB - Treatment with extracorporeal shock wave lithotripsy (ESWL), the preferred method of treating kidney stones <3 cm in size, has been shown to induce silent and often self-limiting acute and chronic lesions in the kidneys and adjacent organs. We conducted a randomized clinical trial to determine whether ESWL produces ischaemia and reperfusion injury in the kidneys and whether oral administration of antioxidants reduces the degree of short-term renal injury in patients treated with ESWL. The study included 120 patients with renal stones (1-3 cm in size) treated with ESWL. The patients were divided into three groups-patients in group A (n = 39) served as a control group and were not given any antioxidants; patients in group B (n = 41) were given two capsules of antioxidants "Nature Made r" 2 h before ESWL, and 2 and 8 h after ESWL; and patients in group C (n = 40) were given two capsules of the antioxidants 2 and 8 h after ESWL. Double 'J' stents were inserted in patients before treatment with ESWL. Blood and urine samples were obtained from all patients just before the start of treatment with ESWL, and at 2 and 24 h and on 7th and 28th day after ESWL. Serum levels of malondialdehyde (MDA), α-tocopherol, cholesterol, albumin and ascorbic acid, and α-tocopherol/cholesterol ratio were determined. Urinary levels of albumin and β2 microglobulin were also determined as measures of renal tubular injury. At 24 h after ESWL, patients given antioxidants (groups B + C) had significantly reduced mean serum concentration of MDA (P < 0.001); higher levels of serum ascorbic acid (P < 0.001) and serum albumin (P < 0.001); lower α-tocopherol/cholesterol ratio, lower urinary albumin and β2 microglobulin levels compared with patients who did not receive antioxidants (group A). These findings suggest that treatment with ESWL generates free radicals through ischaemic/reperfusion injury mechanism, and that oral administration of antioxidant may protect these patients from short term renal injury caused by ESWL.

KW - Antioxidants

KW - Humans

KW - Renal calculi

KW - Renal injury

KW - Shock waves

UR - http://www.scopus.com/inward/record.url?scp=39049132965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049132965&partnerID=8YFLogxK

U2 - 10.1007/s00240-007-0126-0

DO - 10.1007/s00240-007-0126-0

M3 - Article

VL - 36

SP - 51

EP - 60

JO - Urolithiasis

JF - Urolithiasis

SN - 2194-7228

IS - 1

ER -